idarucizumab
navigate by keyword : agent antibody anticoagulant anticoagulation antidote biological biosimilar biotech biotechnology bleeding dabigatran disease drug fragment idarucizumab immunoglobulin immunology infusion injection inn mab monoclonal nomenclature peptide protein reversal surgery thrombin

Dabigatran antidote protein bound to dabigatran. Structure of an antibody-fragment (Fab) that binds the anticoagulant dabigatran, Royalty Free Stock Photo
3D image of Dabigatran skeletal formula Royalty Free Stock Photo
Dabigatran antidote protein bound to dabigatran. 3D Illustration. Royalty Free Stock Photo
Dabigatran antidote protein bound to dabigatran. Structure of an antibody-fragment (Fab) that binds the anticoagulant dabigatran, Royalty Free Stock Photo
Dabigatran antidote protein bound to dabigatran. Structure of an antibody-fragment (Fab) that binds the anticoagulant dabigatran, Royalty Free Stock Photo
   
   
Idarucizumab monoclonal antibody drug. Targets the anticoagulant dabigatran, reversing it's effect (antidote). Generic name and
Dabigatran antidote protein bound to dabigatran. Structure of an antibody-fragment (Fab) that binds the anticoagulant dabigatran, Royalty Free Stock Photo
   
   
   
   
   
   
Idarucizumab monoclonal antibody drug. Targets the anticoagulant dabigatran, reversing it's effect (antidote). Generic name and stylized antibody representation

Stockphotos.ro (c) 2025. All stock photos are provided by Dreamstime and are copyrighted by their respective owners.